With box warnings

Without box warnings

Branded

Generic

2 results

tyvaso
(treprostinil)
United Therapeutics Corporation
Usage: Tyvaso is indicated for treating pulmonary arterial hypertension (PAH) to improve exercise ability in patients, especially those with NYHA Functional Class III symptoms. It is also approved for pulmonary hypertension associated with interstitial lung disease (PH-ILD), enhancing exercise capacity in affected patients.
tyvaso dpi
(treprostinil)
United Therapeutics Corporation
Usage: Tyvaso DPI is indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability in patients, particularly those with NYHA Functional Class III symptoms. It is also indicated for pulmonary hypertension associated with interstitial lung disease (PH-ILD) to enhance exercise capacity.

Medications for Pulmonary Hypertension Due To Interstitial Lung Disease

tyvaso